StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...
Global Bone Growth Stimulator Market is estimated to valued at USD 1.20 Bn in 2024 & expected reach USD 1.71 Bn by 2031, exhibiting CAGR of 5.2% from 2024-2031 ...
The movie adaptation of Tomi Adeyemi's debut YA novel, Children of Blood and Bone, is officially on the horizon. After years in the making, it looks like the literary phenomenon is finally ...
Hosted on MSN15d
Canaccord Genuity Initiates Coverage of Orthofix Medical (OFIX) with Buy RecommendationAnalyst Price Forecast Suggests 35.56% Upside As of December 23, 2024, the average one-year price target for Orthofix Medical is $24.89/share. The forecasts range from a low of $22.22 to a high of ...
report_id=AMR706 The global bone growth stimulators market is highly competitive, with a number of established players as well as new entrants vying for market share. Key players in the market include ...
Comparatively, Orthofix Medical has a beta of 1.1 ... The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and ...
Kansas State forward Ayoka Lee will be sidelined indefinitely after an X-ray and MRI exam revealed the All-American fractured a bone in her foot in the second quarter of the No. 10 Wildcats’ win ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback